These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 32039436)

  • 61. Biological therapies in the spondyloarthritides--the current state.
    Braun J; Sieper J
    Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Monotherapy in rheumatoid arthritis.
    Scher JU
    Bull Hosp Jt Dis (2013); 2013; 71(3):204-7. PubMed ID: 24151946
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reactive arthritis, diagnosis and treatment: a review.
    Nordstrom DC
    Acta Orthop Scand; 1996 Apr; 67(2):196-201. PubMed ID: 8623582
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis.
    Ravindran V; Scott DL; Choy EH
    Ann Rheum Dis; 2008 Jun; 67(6):855-9. PubMed ID: 17827183
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Can serum interleukin-17 and interleukin-10 levels predict response to biologic treatments in patients with rheumatoid arthritis?
    McDonald S; Reed R; Baricevic-Jones I; ; Ling S; Plant D; Barton A
    Rheumatology (Oxford); 2019 Oct; 58(10):1872-1873. PubMed ID: 31329971
    [No Abstract]   [Full Text] [Related]  

  • 66. Indirect comparisons of the efficacy of biological agents in patients with psoriatic arthritis with an inadequate response to traditional disease-modifying anti-rheumatic drugs or to non-steroidal anti-inflammatory drugs: A meta-analysis.
    Ungprasert P; Thongprayoon C; Davis JM
    Semin Arthritis Rheum; 2016 Feb; 45(4):428-38. PubMed ID: 26610638
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pharmacologic Therapies for Rheumatologic and Autoimmune Conditions.
    Bays AM; Gardner G
    Med Clin North Am; 2016 Jul; 100(4):719-31. PubMed ID: 27235612
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The role of concomitant methotrexate in biologic therapy for rheumatoid arthritis.
    Ruderman EM
    Bull Hosp Jt Dis (2013); 2013; 71 Suppl 1():S29-32. PubMed ID: 24219038
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reactive arthritis: is it a useful concept?
    Beutler AM; Schumacher HR
    Br J Clin Pract; 1997; 51(3):169-72. PubMed ID: 9293060
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Aberrant TNF secretion by whole blood in healthy subjects with a history of reactive arthritis: time course in adherent and non-adherent cultures.
    Anttonen K; Orpana A; Leirisalo-Repo M; Repo H
    Ann Rheum Dis; 2006 Mar; 65(3):372-8. PubMed ID: 16107515
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increased synovial fluid levels of interleukin-12, sCD25 and sTNF-RII/sTNF-RI ratio delineate a cytokine pattern characteristic of immune arthropathies.
    Ribbens C; André B; Kaye O; Kaiser MJ; Bonnet V; de Groote D; Franchimont N; Malaise MG
    Eur Cytokine Netw; 2000 Dec; 11(4):669-76. PubMed ID: 11125312
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drug treatment for rheumatoid arthritis.
    Langenegger T; Michel BA
    Clin Orthop Relat Res; 1999 Sep; (366):22-30. PubMed ID: 10627714
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Response to treatment with tocilizumab of reactive arthritis induced by intravesical bacillus Galmette-Guérin unresponsive to DMARDs.
    Kwan K; Bharadwaj S; Inderjeeth C
    Int J Rheum Dis; 2012 Aug; 15(4):e73-5. PubMed ID: 22898231
    [No Abstract]   [Full Text] [Related]  

  • 74. Effects of synthetic and biological disease modifying antirheumatic drugs on lipid and lipoprotein parameters in patients with rheumatoid arthritis.
    Naerr GW; Rein P; Saely CH; Drexel H
    Vascul Pharmacol; 2016 Jun; 81():22-30. PubMed ID: 26903239
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Reactive arthritis.
    Petersel DL; Sigal LH
    Infect Dis Clin North Am; 2005 Dec; 19(4):863-83. PubMed ID: 16297737
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Rheumatoid arthritis: progress in diagnosis and treatment. Topics: IV. Treatment 2. Antirheumatic agents, 2) biological agents].
    Amano K
    Nihon Naika Gakkai Zasshi; 2012 Oct; 101(10):2880-5. PubMed ID: 23214097
    [No Abstract]   [Full Text] [Related]  

  • 77. Gastrointestinal Perforations with Biologics in Patients with Rheumatoid Arthritis: Implications for Clinicians.
    Jagpal A; Curtis JR
    Drug Saf; 2018 Jun; 41(6):545-553. PubMed ID: 29392593
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Biologics-induced interstitial lung diseases in rheumatic patients: facts and controversies.
    Chen J; Chi S; Li F; Yang J; Cho WC; Liu X
    Expert Opin Biol Ther; 2017 Mar; 17(3):265-283. PubMed ID: 28117616
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Role of TNFRp55 in Yersinia enterocolitica O:3-induced arthritis: triggering bacterial antigens and articular immune response.
    Di Genaro MS; Cargnelutti DE; Eliçabe JR; Lacoste MG; Valdez S; Gómez N; de Guzmán AM
    Rheumatology (Oxford); 2007 Apr; 46(4):590-6. PubMed ID: 17043042
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers.
    Shimada H; Kameda T; Kanenishi K; Miyatake N; Nakashima S; Wakiya R; Kato M; Miyagi T; Mansour MMF; Hata T; Kadowaki N; Dobashi H
    Clin Rheumatol; 2019 May; 38(5):1453-1458. PubMed ID: 30729372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.